Zobrazeno 1 - 10
of 12
pro vyhledávání: '"W P. Olszynski"'
Autor:
L-A, Fraser, G, Ioannidis, J D, Adachi, L, Pickard, S M, Kaiser, J, Prior, J P, Brown, D A, Hanley, W P, Olszynski, T, Anastassiades, S, Jamal, R, Josse, D, Goltzman, A, Papaioannou, Brian, Lentle
Publikováno v:
Osteoporosis International. 22:789-796
Canadian women over 50 years old were studied over a 10-year period to see if those who sustained a fracture (caused by minimal trauma) were receiving the recommended osteoporosis therapy. We found that approximately half of these women were not bein
Publikováno v:
Journal of Musculoskeletal & Neuronal Interactions
Background: Least Significant Change (LSC) assists in determining whether observed bone change is beyond measurement precision. Monitoring Time Interval (MTI) estimates time required to reliably detect skeletal changes. MTIs have not been defined for
Autor:
C Kasibhatla, Ignac Fogelman, Michael W. J. Davie, Charles H. Chesnut, Piet Geusens, W P Olszynski, N Alsayed, T M Zizic, G.C. Isaia, Robert P. Heaney
Publikováno v:
Osteoporosis International. 13:501-505
Risedronate treatment reduces the risk of vertebral fracture in women with existing vertebral fractures, but its efficacy in prevention of the first vertebral fracture in women with osteoporosis but without vertebral fractures has not been determined
Autor:
L A, Langsetmo, S, Morin, J B, Richards, K S, Davison, W P, Olszynski, J C, Prior, R, Josse, D, Goltzman, Brian C, Lentle
Publikováno v:
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 20(2)
Observational studies are needed to quantify real-life effectiveness of antiresorptive therapy in the prevention of clinical fractures. Antiresorptive therapies were associated with an overall 32% reduction in low-trauma nonvertebral fracture risk am
Autor:
Mark Lemstra, W P. Olszynski
Publikováno v:
Spine. 29(14)
A prospective cohort.To compare the effectiveness of standard care, early intervention treatment, and occupational management in the management of Workers' Compensation injury claims.The current management of occupational back pain and work-related u
Publikováno v:
Headache. 42(9)
Objective.—To test the effectiveness of a multidisciplinary management program for migraine treatment in a group, low cost, nonclinical setting. Design.—A prospective, randomized, clinical trial. Background.—Although numerous studies document t
Publikováno v:
The Journal of rheumatology. 23(9)
To evaluate viscosupplementation with intraarticular hylan G-F 20 in current clinical practice.A retrospective study of all patients with osteoarthritis of the knee treated with hylan by 5 Canadian clinicians over a period of 2.5 years.A total of 153
Publikováno v:
The Journal of rheumatology. 20(2)
We describe a family in which 3 members each developed systemic lupus erythematosus complicated by ischemic vasculopathy. The calendar years and patient ages of disease onset and the clinical courses were remarkably similar for all 3 patients, althou
Publikováno v:
The Journal of rheumatology. 19(1)
In a review of our experience with systemic lupus erythematosus (SLE) since 1975, we found 48 of 266 patients with major central nervous system (CNS) manifestations for which a non-SLE explanation could not be identified. Eleven patients developed mo
Autor:
J. D. Adachi, G. Ioannidis, L. Pickard, C. Berger, J. C. Prior, L. Joseph, D. A. Hanley, W. P. Olszynski, T. M. Murray, T. Anastassiades, W. Hopman, J. P. Brown, S. Kirkland, C. Joyce, A. Papaioannou, S. Poliquin, A. Tenenhouse, E. A. Papadimitropoulos
Publikováno v:
Osteoporosis International; Nov2003, Vol. 14 Issue 11, p895-904, 10p